Cargando…

Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis

INTRODUCTION: Gastro-oesophageal reflux is common in patients with oesophagogastric junction (OGJ) cancer following radical surgery. We aim to conduct a systematic review to investigate the effectiveness and clinical value of additional antireflux surgery (pyloroplasty and fundoplication) for OGJ ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Na, Zheng, Peng, Yu, Yang, Gao, Lei, Li, Yu, Ding, Fanghui, Wang, Bofang, Chen, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806086/
https://www.ncbi.nlm.nih.gov/pubmed/36581436
http://dx.doi.org/10.1136/bmjopen-2022-066061
_version_ 1784862458791329792
author Wang, Na
Zheng, Peng
Yu, Yang
Gao, Lei
Li, Yu
Ding, Fanghui
Wang, Bofang
Chen, Hao
author_facet Wang, Na
Zheng, Peng
Yu, Yang
Gao, Lei
Li, Yu
Ding, Fanghui
Wang, Bofang
Chen, Hao
author_sort Wang, Na
collection PubMed
description INTRODUCTION: Gastro-oesophageal reflux is common in patients with oesophagogastric junction (OGJ) cancer following radical surgery. We aim to conduct a systematic review to investigate the effectiveness and clinical value of additional antireflux surgery (pyloroplasty and fundoplication) for OGJ cancer. METHODS AND ANALYSIS: We intend to search Medline, Cochrane Library and Embase databases for studies published in English, from database inception to October 2022. Randomised controlled trials and (non-random) controlled clinical trials will be eligible for inclusion. We will search for all eligible studies that have compared proximal gastrectomy plus additional antireflux surgery and proximal gastrectomy alone in patients with resectable OGJ cancer. All potential outcomes related to gastro-oesophageal reflux, including occurrence of reflux symptoms, reflux oesophagitis, reflux occurrence based on barium meal examination, pH of fluid from the lower oesophagus, and 24-hour oesophageal pH test will be assessed as the primary outcomes. Other outcomes, such as patients’ survival and postoperative complications (eg, stenosis, infection and leak) will also be analysed. Two reviewers will independently screen the literature, extract data and assess the risk of bias in the included studies; subsequently, a meta-analysis will be performed using RevMan V.5.3 software to pool the results. The χ(2) and I(2) tests will be used for heterogeneity assessment and sources of heterogeneity will be explored using subgroup analysis. The Grading of Recommendations, Assessment, Development and Evaluation method will be applied to assess the level of evidence. ETHICS AND DISSEMINATION: This proposed study is a secondary analysis of previously published data. Therefore, ethics approval is not required. The results will be presented for publication in a peer-reviewed journal and data will be stored in public databases.
format Online
Article
Text
id pubmed-9806086
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-98060862023-01-03 Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis Wang, Na Zheng, Peng Yu, Yang Gao, Lei Li, Yu Ding, Fanghui Wang, Bofang Chen, Hao BMJ Open Oncology INTRODUCTION: Gastro-oesophageal reflux is common in patients with oesophagogastric junction (OGJ) cancer following radical surgery. We aim to conduct a systematic review to investigate the effectiveness and clinical value of additional antireflux surgery (pyloroplasty and fundoplication) for OGJ cancer. METHODS AND ANALYSIS: We intend to search Medline, Cochrane Library and Embase databases for studies published in English, from database inception to October 2022. Randomised controlled trials and (non-random) controlled clinical trials will be eligible for inclusion. We will search for all eligible studies that have compared proximal gastrectomy plus additional antireflux surgery and proximal gastrectomy alone in patients with resectable OGJ cancer. All potential outcomes related to gastro-oesophageal reflux, including occurrence of reflux symptoms, reflux oesophagitis, reflux occurrence based on barium meal examination, pH of fluid from the lower oesophagus, and 24-hour oesophageal pH test will be assessed as the primary outcomes. Other outcomes, such as patients’ survival and postoperative complications (eg, stenosis, infection and leak) will also be analysed. Two reviewers will independently screen the literature, extract data and assess the risk of bias in the included studies; subsequently, a meta-analysis will be performed using RevMan V.5.3 software to pool the results. The χ(2) and I(2) tests will be used for heterogeneity assessment and sources of heterogeneity will be explored using subgroup analysis. The Grading of Recommendations, Assessment, Development and Evaluation method will be applied to assess the level of evidence. ETHICS AND DISSEMINATION: This proposed study is a secondary analysis of previously published data. Therefore, ethics approval is not required. The results will be presented for publication in a peer-reviewed journal and data will be stored in public databases. BMJ Publishing Group 2022-12-29 /pmc/articles/PMC9806086/ /pubmed/36581436 http://dx.doi.org/10.1136/bmjopen-2022-066061 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Oncology
Wang, Na
Zheng, Peng
Yu, Yang
Gao, Lei
Li, Yu
Ding, Fanghui
Wang, Bofang
Chen, Hao
Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
title Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
title_full Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
title_fullStr Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
title_full_unstemmed Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
title_short Effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
title_sort effectiveness of additional antireflux surgery after resection of oesophagogastric junction cancer: protocol for a systematic review and meta-analysis
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9806086/
https://www.ncbi.nlm.nih.gov/pubmed/36581436
http://dx.doi.org/10.1136/bmjopen-2022-066061
work_keys_str_mv AT wangna effectivenessofadditionalantirefluxsurgeryafterresectionofoesophagogastricjunctioncancerprotocolforasystematicreviewandmetaanalysis
AT zhengpeng effectivenessofadditionalantirefluxsurgeryafterresectionofoesophagogastricjunctioncancerprotocolforasystematicreviewandmetaanalysis
AT yuyang effectivenessofadditionalantirefluxsurgeryafterresectionofoesophagogastricjunctioncancerprotocolforasystematicreviewandmetaanalysis
AT gaolei effectivenessofadditionalantirefluxsurgeryafterresectionofoesophagogastricjunctioncancerprotocolforasystematicreviewandmetaanalysis
AT liyu effectivenessofadditionalantirefluxsurgeryafterresectionofoesophagogastricjunctioncancerprotocolforasystematicreviewandmetaanalysis
AT dingfanghui effectivenessofadditionalantirefluxsurgeryafterresectionofoesophagogastricjunctioncancerprotocolforasystematicreviewandmetaanalysis
AT wangbofang effectivenessofadditionalantirefluxsurgeryafterresectionofoesophagogastricjunctioncancerprotocolforasystematicreviewandmetaanalysis
AT chenhao effectivenessofadditionalantirefluxsurgeryafterresectionofoesophagogastricjunctioncancerprotocolforasystematicreviewandmetaanalysis